Press Release


 Amexdrug Corp. Admitted to Two Important Industry Organizations

Wed, Apr 04, 2007

Amexdrug Corporation (OTCBB: AXRX) announced today that its applications for membership have been reviewed and approved for admittance into the National Association of Chain Drug Stores (www.nacds.org) and the Cosmetic, Toiletry, and Fragrance Association (www.ctfa.org). Both are important industry associations that contribute substantially to the success and visibility of their members, providing a forum for members to interact and share the benefits of their experience. In addition, these organizations offer support and a superb knowledge base, including market analyses and industry data that are invaluable resources for companies seeking to make educated and informed decisions on the basis of perceptible trends in the market.

According to Jack Amin, President and CEO of Amexdrug Corp., "We are glad to have been admitted to both of these highly respected industry organizations, particularly because of the support and assistance that we believe they can provide. The extensive knowledge base and the ability to interact with other members of the industry should be invaluable assets as we continue to refine our strategy and explore additional opportunities." Mr. Amin added, "As we expand our product offerings and grow our business, the ability to make informed decisions about trends and directions in the industry is particularly important, and our membership in these associations will help us to gauge such trends."

Amexdrug Corp. Unveils New Product Line

Wed, Mar 21, 2007
Amexdrug Corporation (OTCBB: AXRX) today announced that it has completed formulation and market analysis, and has moved on to the initial production phase of its new line of five over-the-counter products aimed at fungal infections, brittle nails, as well as a topical analgesic. These over-the-counter natural products will be manufactured using all FDA-approved ingredients through Amexdrug's subsidiary Dermagen, Inc., and will be sold and marketed through another Amexdrug subsidiary, BioRX Pharmaceuticals.

The preliminary stage of the marketing plan calls for the products to be sold and marketed through chain drug stores, natural food and health stores, and sports chain stores across the United States, with subsequent sales and marketing to expand internationally. Company research indicates that between 30 and 40 million Americans suffer from some type of persistent fungal infection and/or brittle and unsightly nails, and more than 1 billion people suffer from fungal infections worldwide. In addition, the U.S. market for over-the-counter (OTC) anti-infective products surpassed $2 billion in 2005. Finally, the U.S. market for antiarthritic drugs and analgesics has grown from $9.1 billion in 2000 to $13.5 billion in 2004. As a consequence, Amexdrug is extremely confident that there is more than sufficient market demand for these new products.

According to a company spokesperson, "Our market research has shown evidence of significant demand sectors, making this one of the Company's more anticipated product releases. Based on our research, we are confident that these latest offerings will have an immediate positive impact on revenues once we unveil them in mid-April of this year. Utilizing a review of competitive pricing structures and our initial internal cost analysis, the Company strongly believes that sales of these products will provide exceptional margins, and so we are understandably eagerly awaiting their imminent arrival on the marketplace."

Dermagen Inc. Hits Potential 45,000 at Top Industry Trade Show
Mon, Jan 30, 2006
Dermagen Incorporated, a wholly owned subsidiary of Amexdrug Corporation (OTC BB: AXRX), is proud to announce their participation at the Westpack 2006 Medical Packaging Expo. Westpack this year is expected to have over 45,000 suppliers, buyers, and potential clients for the US-FDA registered and state FDA approved Dermagen Labs. Located at the center of the highest concentration of manufacturing on the West Coast, WestPack is a key part of the nation's largest annual manufacturing tradeshow. California's manufacturing decision makers can source over 3000 suppliers... the most comprehensive presentation of machinery, materials, components and contract services in the United States. Westpack is the only show that delivers California's $35 billion packaging marketplace.

Jack Amin, President & CEO of Amexdrug Corporation, stated, "We feel by being at this show that it's just another revolutionary step for Amexdrug to grow shareholder value and become a household name in the beauty products and packaging industries." Mr. Amin went on to say, "With over 3000 suppliers in this $35 Billion industry, once we present our products we are confident that it will be received positively by the industry with immediate potential to boost revenues and widen margins!"

This year's Westpack 2006 Expo is located at The Anaheim Convention Center, at 800 W. Katella Ave., Anaheim, California 92802 (Halls A, B, C, D, and The Arena) on Tuesday-Thursday January 31-February 2, between the hours 10:00 A.M. - 5:00 P.M. (Thursday exhibit hall closes at 4:00PM). Dermagen Labs & Manufacturing will be located at Booth #4998A. For more information you can go to http://www.devicelink.com/expo/wpack06/index.html or contact Amexdrug directly at 310-855-0475. We expect this trade show will increase our customer base and increase revenue.